|
VPS37C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.831790E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.863590E-02 |
| Normal-vs-Stage2 |
5.963200E-01 |
| Normal-vs-Stage3 |
3.970200E-02 |
| Normal-vs-Stage4 |
4.207400E-04 |
| Stage1-vs-Stage2 |
4.255000E-01 |
| Stage1-vs-Stage3 |
5.118200E-01 |
| Stage1-vs-Stage4 |
8.473700E-02 |
| Stage2-vs-Stage3 |
2.857400E-01 |
| Stage2-vs-Stage4 |
5.689500E-02 |
| Stage3-vs-Stage4 |
2.461800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.724200E-03 |
| Normal-vs-AfricanAmerican |
2.240000E-01 |
| Normal-vs-Asian |
6.950600E-01 |
| Caucasian-vs-AfricanAmerican |
3.060800E-01 |
| Caucasian-vs-Asian |
9.935800E-01 |
| AfricanAmerican-vs-Asian |
8.726200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.863400E-03 |
| Normal-vs-Female |
2.536800E-01 |
| Male-vs-Female |
2.747800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.424100E-03 |
| Normal-vs-Extreme_Weight |
1.256300E-02 |
| Normal-vs-Obese |
2.581200E-01 |
| Normal-vs-Extreme_Obese |
4.208800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.360200E-01 |
| Normal_Weight-vs-Obese |
6.361600E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.033400E-01 |
| Extreme_Weight-vs-Obese |
2.583400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.257800E-01 |
| Obese-vs-Extreme_Obese |
9.854800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.812800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.803400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.780110E-03 |
| Normal-vs-Age(81-100Yrs) |
1.192680E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.909200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.575440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.214500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.110100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.699900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.028000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.202610E-01 |
| Normal-VS-Type2 PRCC |
1.010390E-04 |
| Normal-VS-KIRP CIMP |
2.212500E-02 |
| Normal-VS-Unclassified PRCC |
6.928800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.780100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.919800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.312970E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.192600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.398400E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
7.916200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.315700E-02 |
| Normal-vs-N1 |
1.883720E-02 |
| Normal-vs-N2 |
9.246500E-02 |
| N0-vs-N1 |
4.277200E-01 |
| N0-vs-N2 |
6.880400E-01 |
| N1-vs-N2 |
9.725000E-01 |
|
|
